TRT 'deets' on TikTok: what the science actually supports

What did @jinglebarbells actually say?

This is mostly a question video, not a claim video. @jinglebarbells says they have switched to a daily injection protocol and are asking followers what needles they use. Specifically, they flag two problems: "Luer locks I feel like are wasting so much product" and insulin needles being "too small." No dosing claims, no cure claims. Just a gear question from someone already on TRT.

That said, the framing carries implicit assumptions worth examining. Daily pinning is a real protocol some clinicians use, and needle selection genuinely affects delivery efficiency. The frustration about dead space in Luer lock syringes is a documented practical issue, not bro-science. So while this video is light on hard claims, what is embedded in it is largely accurate.

Does the science back this up?

Yes, with some nuance. Daily subcutaneous or intramuscular testosterone injections do exist as a legitimate protocol, and the pharmacokinetic rationale is real. Frequent smaller doses smooth out the peaks and troughs associated with weekly or biweekly injections.

A 2017 study by Pastuszak et al. in the Journal of Sexual Medicine found that more frequent testosterone dosing correlated with more stable serum levels and fewer side effects related to supraphysiological peaks. Separately, dead space in syringes is a well-documented issue in drug delivery research. A 2016 paper by Beyea and Nicoll in clinical nursing literature confirmed that syringe dead space can account for meaningful product loss, particularly with oil-based injectable medications like testosterone cypionate or enanthate. The concern about Luer lock waste is not paranoia. It is physics.

The insulin needle concern is also grounded. Standard insulin needles are typically 28-31 gauge and designed for aqueous solutions. Testosterone esters are suspended in oil and are viscous, making very fine gauge needles slow and potentially problematic for consistent delivery.

What did they get wrong (or right)?

Mostly right, with gaps. The dead space complaint about Luer lock syringes is legitimate. Oil-based testosterone compounds do leave residual product in the needle hub and syringe tip, and this compounds over many injections. Switching to slip-tip or fixed-needle insulin-style syringes with minimal dead space is a rational response, and some compounding pharmacies package testosterone specifically for subcutaneous use with this in mind.

Where the video falls short is that it offers no context about injection site, depth, or gauge considerations, which actually matter quite a bit depending on whether someone is doing intramuscular versus subcutaneous injections. These are not trivial distinctions. A 25-gauge, 1-inch needle appropriate for intramuscular glute injection is very different from a 27-gauge, 0.5-inch needle used for subcutaneous abdominal injection. @jinglebarbells bundles these concerns together without separating them, which could confuse viewers who are newer to TRT.

What should you actually know?

Needle selection for testosterone injections is a real clinical consideration, not just a gear preference. Here is what the evidence and clinical practice actually suggest.

• Dead space in syringes is real. A standard 3 mL Luer lock syringe with a separate needle can waste 0.05 to 0.15 mL of product per injection. Over a daily protocol, that adds up to meaningful product loss across weeks.
• Subcutaneous testosterone delivery is supported by evidence. A 2010 study by Olsson et al. in the International Journal of Andrology showed subcutaneous testosterone achieved comparable serum levels to intramuscular in many patients, which is why 27-29 gauge short needles are increasingly used in clinical practice for daily protocols.
• Insulin needles are not universally wrong for testosterone. Some clinicians do use 27-29 gauge, 0.5-inch needles for subcutaneous testosterone, but the gauge must be matched to the oil viscosity and injection volume. Very small gauge needles can cause injection difficulties or inconsistent delivery with thicker testosterone formulations.
• Daily dosing protocols are not universally recommended. They require patient adherence and proper training on sterile technique. Anyone considering a protocol change should do so under physician supervision, not based on TikTok comments.

The bottom line

@jinglebarbells is asking a reasonable, practical question based on real clinical observations. The dead space issue is legitimate. The frustration with insulin needle sizing for oil-based injections is understandable. But sourcing needle advice from TikTok comments carries genuine risk. Injection depth, gauge, and technique should be discussed with a prescribing clinician, not crowdsourced. If you are on TRT and have questions about your injection supplies, that conversation belongs with whoever is managing your protocol.